Achieve Life Sciences, Inc. (ACHV)
Total Valuation
ACHV has a market cap or net worth of $87.20 million. The enterprise value is $83.56 million.
| Market Cap | 87.20M |
| Enterprise Value | 83.56M |
Important Dates
The last earnings date was Thursday, November 9, 2023, after market close.
| Earnings Date | Nov 9, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHV has 21.17 million shares outstanding. The number of shares has increased by 117.95% in one year.
| Shares Outstanding | 21.17M |
| Shares Change (YoY) | +117.95% |
| Shares Change (QoQ) | +10.91% |
| Owned by Insiders (%) | 7.70% |
| Owned by Institutions (%) | 33.32% |
| Float | 20.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 21.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.36, with a Debt / Equity ratio of 4.03.
| Current Ratio | 5.36 |
| Quick Ratio | 4.90 |
| Debt / Equity | 4.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.61 |
Financial Efficiency
Return on equity (ROE) is -632.90% and return on invested capital (ROIC) is -166.01%.
| Return on Equity (ROE) | -632.90% |
| Return on Assets (ROA) | -136.80% |
| Return on Capital (ROIC) | -166.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.78M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.57% in the last 52 weeks. The beta is 1.60, so ACHV's price volatility has been higher than the market average.
| Beta (1Y) | 1.60 |
| 52-Week Price Change | +61.57% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 5.44 |
| Relative Strength Index (RSI) | 47.25 |
| Average Volume (30 Days) | 80,743 |
Short Selling Information
The latest short interest is 707,197, so 3.34% of the outstanding shares have been sold short.
| Short Interest | 707,197 |
| Short Previous Month | 686,549 |
| Short % of Shares Out | 3.34% |
| Short % of Float | 3.38% |
| Short Ratio (days to cover) | 5.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -33.73M |
| Pretax Income | -35.57M |
| Net Income | -35.57M |
| EBITDA | -32.72M |
| EBIT | -32.96M |
| Earnings Per Share (EPS) | -$2.03 |
Balance Sheet
The company has $19.92 million in cash and $16.28 million in debt, giving a net cash position of $3.64 million or $0.17 per share.
| Cash & Cash Equivalents | 19.92M |
| Total Debt | 16.28M |
| Net Cash | 3.64M |
| Net Cash Per Share | $0.17 |
| Equity / Book Value | 4.04M |
| Book Value Per Share | 0.19 |
| Working Capital | 17.82M |
Cash Flow
| Operating Cash Flow | -31.26M |
| Capital Expenditures | n/a |
| Free Cash Flow | -31.26M |
| FCF Per Share | -$1.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -40.79% |
| FCF Yield | -35.85% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -117.95% |
| Shareholder Yield | -117.95% |
Analyst Forecast
The average price target for ACHV is $18.50, which is 349.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.50 |
| Price Target Difference | 349.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 31, 2020. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jul 31, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |